By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.


Fresenius Continues to Advance NxStage Acquisition

Fresenius is on track to close its acquisition of NxStage on the timeline that the parties have indicated to the market, CTFN has learned.featured

Five Essentials from CTFN This Week

A decision in the Aetna/CVS Health merger is likely to come in the next three to six weeks, according to a former assistant section chief in the healthcare and consumer products section within the Department of Justice’s antitrust division. More here ” U.S. state insurance department reviews of AXA’s $15.3 billion acquisition of Bermuda-based XL … Read Morefeatured

Implications of Bloodlines Sale for FTC Review of NxStage/Fresenius

NxStage agreed on July 10 to sell its bloodlines business, operated under the Medisystems name, to B. Braun Medical, subject to approval by the U.S. Federal Trade Commission and thefeatured

Four Essentials from CTFN This Week

Industrial gas giants Linde and Praxair are in discussions with Latin American regulators for the sale of the overlapping assets that will need to be divested to gain clearance for their planned merger. More here ” As the pleading cycle for the Tribune/Sinclair merger comes to a close, it appears unlikely the Federal Communications Commission … Read Morefeatured

NxStage/Fresenius Review Lingers at FTC

Fresenius and NxStage are several months into a timing agreement with the Federal Trade Commission as the agency continues its review of the companies’ pendingfeatured

Three Essentials from CTFN This Week

The regulatory overhaul leading to the creation of China’s State Administration for Market Regulation (SAMR) is affecting ongoing merger reviews,featured

Manageable Divestiture Likely in the Works for NxStage/Fresenius Merger

Antitrust attorneys working with third parties told CTFN that a divestiture of NxStage’s bloodline tubing unit is being discussed as a condition infeatured

Four Essentials from CTFN This Week

The Competition Commission of India looks likely to use all the time up to its internal deadline for concluding its review of Bayer’s acquisition of Monsanto, with a decision still one or two weeks away, sources told CTFN. More here ” The administrative tribunal of Brazilian antitrust regulator CADE is expected to vote on the … Read Morefeatured

Fresenius Appears to Make Progress at FTC with NxStage Merger

An attorney working with a third party told CTFN that Fresenius and NxStage have strong arguments and that the companies are making their case well tofeatured

Four Essentials from CTFN This Week

CTFN’s Ed Roberts was in court for the entirety of the proceedings in the Department of Justice’s suit challenging the merger of Time Warner and AT&T. Ed’s notes are routinely posted and updated throughout each day. For his latest posting, please see here ” Growing trade tensions between China and the United States will not … Read Morefeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.